Table 3 Viral nucleic acid negative-conversion within 14 days and not negative rate at last assay in different treatment groups
Feature | Without Arbidol (n = 63)a | With Arbidol (n = 99) | p value | OR (95% CI) |
|---|---|---|---|---|
Time to PCR negative in respiratory specimens | ||||
≤ 14 days (%) | 35 (55.6) | 72 (72.7) | 0.028* | 0.47 (0.24, 0.91) |
> 14 days (%) | 28 (44.4) | 27 (27.3) | 0.028* | |
Not negative (%) | 9 (14.3) | 5 (5.1) | 0.049* | 3.13 (1.00, 9.83) |
Control (n = 32) | Other antiviral drugs (n = 31) | Arbidol only (n = 69) | Arbidol + other antiviral drugs (n = 30) | |
|---|---|---|---|---|
≤ 14 days (%) | 14 (43.8) | 21 (67.7) | 53 (76.8)*b | 19 (63.3) |
> 14 days (%) | 18 (56.2) | 10 (32.3) | 16 (23.2) | 11 (36.7) |
Not negative (%) | 6 (18.8) | 3 (9.7) | 5 (7.2) | 0 (0.00) |